Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
US-10111968-B2 · Oct 30, 2018 · US
US9752154B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9752154-B2 |
| Application number | US-201314416799-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 23, 2013 |
| Priority date | Jul 26, 2012 |
| Publication date | Sep 5, 2017 |
| Grant date | Sep 5, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention is related to methods and systems for vector assembly for transgenic plants. A uniform modular process is used to reduce cycle time and the methods and systems provided herein can increase cloning throughput using multiple-well plates, for example 96-well plates. In some embodiments, the methods and systems provided herein eliminate or reduce the need for sequencing confirmation because no PCR is involved in the vector assembly process.
Opening claim text (preview).
We claim: 1. A method for DNA assembly, comprising, (a) providing a first DNA molecule comprising a Kozak sequence, wherein the Kozak sequence is selected from the group consisting of SEQ ID NOs: 1-43 and 64-74; (b) providing a second DNA molecule comprising the same Kozak sequence of step (a) at one end and a six frame stop sequence at the other end, wherein the six frame stop sequence is selected from the group consisting of SEQ ID NOs: 75-80; (c) providing a third DNA molecule comprising the same six frame stop sequence of step (b); (d) providing a fourth DNA molecule comprising a linear vector sequence; and (e) assembling a product vector using the DNA molecules of steps (a), (b), (c), and (d) in the presence of at least one recombinase, where the Kozak sequence and the six frame stop sequence provide junction homologies for DNA recombination and wherein the product vector has sequences in the order of the DNA molecules from steps (a), (b), (c), and (d). 2. The method of claim 1 , wherein the DNA molecules of steps (a), (b), (c), and (d) are obtained using PCR amplification or direct DNA synthesis. 3. The method of claim 1 , wherein no DNA amplification technique is used. 4. The method of claim 1 , wherein polymerase chain reaction is not used. 5. The method of claim 1 , wherein the fourth DNA molecule comprises a lethal gene. 6. The method of claim 5 , wherein the lethal gene is ccdB. 7. The method of claim 1 , wherein the same Kozak sequence of both step (a) and (b) comprises a same three-frame stop sequence at its 5′ end. 8. The method of claim 7 , wherein the three-frame stop sequence is selected from the group consisting of SEQ ID NOS 44-62.
Stabilisation of the vector · CPC title
for plant cells {, e.g. plant artificial chromosomes (PACs)} · CPC title
Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.